Rickettsia rickettsii IgG & IgM Abs




Test Mnemonic

ROCKY

CPT Codes

  • 86757 - QTY (2)

Aliases

  • Rocky Mountain Spotted Fever
  • Tick-Borne Diseases

Includes

  • R. rickettsii IgG Abs
  • R. rickettsii IgM Abs

Performing Laboratory

ARUP


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) RefrigeratedSeparate serum from cells ASAP or within 2 hours of collection and transfer to standard aliquot tube. Parallel testing is preferred and convalescent specimens MUST be received within 30 days from receipt of the acute specimens. Label specimens plainly as 'acute' or 'convalescent.'

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.4 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: 48 hours
RefrigeratedAfter separation from cells: 2 weeks
FrozenAfter separation from cells: 1 year (Avoid repeated freeze/thaw cycles)

Days Performed

Sun - Sat

Turnaround Time

2 - 4 days

Methodology

Name Description
Semi-Quantitative Indirect Fluorescent Antibody 

Reference Range

R. rickettsii IgG Abs
Sex Age From Age To Type Range Range Unit
       NormalLow Positive: 1:64 - 1:128titer
       NormalNegative: <1:64titer
       NormalPositive: 1:256 and greatertiter
R. rickettsii IgM Abs
Sex Age From Age To Type Range Range Unit
       NormalNegative: <1:64titer
       NormalPositive: 1:64 and greatertiter

Special Info

Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Contaminated, hemolyzed, or severely lipemic specimens are unacceptable. This test is New York DOH approved.

Clinical Info

This is the preferred test for acute or convalescent phase of disease. Acute and convalescent titers are often necessary. Antibody reactivity to Rickettsia rickettsii antigen should be considered Spotted Fever group reactive. Other organisms within the group include R. akari, R. conorrii, R. australis, and R. sibirica. Seroconversion, a fourfold or greater rise in antibody titer, between acute and convalescent sera is considered strong evidence of recent infection. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute-phase of illness, submit a labeled convalescent sample within 25 days for paired testing. The CDC does not use IgM results for routine diagnostic testing of Rocky Mountain Spotted Fever, as the response may not be specific for the agent (resulting in false positives) and the IgM response may be persistent from past infection.